A Bozza

P506Brugada Syndrome: is the addition of the electrocardiographic risk markers the clue?

A. Tronconi, Gabriela S. Carnero, Mauricio Mysuta, A Bozza et autres

Abstract Background Risk stratification in Brugada Syndrome (BS) remains a clinical challenge. Several electrocardiografic (ECG) risk markers had been described, as a spontaneous type 1 Brugada pattern (ST1B), maximal time interval between the peak and the end of the t wave in …

ar (code pays fourni par la source)

P1169Cardiac resynchronization theraphy. Long term benefit

Néstor O. Galizio, Mona Peltzer, A. Tronconi, Gabriela S. Carnero et autres

Abstract Introduction The benefit of cardiac resynchronization therapy (CRT) in patients (pts) with left ventricular dysfunction is mainly evaluated in multicenter studies with a follow up of 6, 12 or 24 months (m). Objectives To describe the response of pts implanted with …

ar (code pays fourni par la source)

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

Sean D. Pokorney, Jonathan Paul Piccini, Susanna R. Stevens, Manesh R. Patel et autres

BACKGROUND: Atrial fibrillation is associated with higher mortality. Identification of causes of death and contemporary risk factors for all-cause mortality may guide interventions. METHODS AND RESULTS: In the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for …

us, de, au, gb (code pays fourni par la source)

III Diretriz sobre tratamento do infarto agudo do miocárdio

Leopoldo Soares Piegas, Ari Timerman, José Carlos Nicolau, Luiz Alberto Mattos et autres

Classe I: evidência ou concordância geral de que o tratamento é benéfico, útil e eficaz.Classe II: evidência conflitante e/ou divergência de opinião quanto à utilidade e à eficácia do tratamento.Classe IIa: forças das evidências/opiniões em favor da utilidade e da eficácia.Classe IIb: …

[Myocardial ischemia with stable angina pectoris: clinico-ergometric evaluation after the use of diltiazem].

Maranhão Mf, de Castro, F M Albanesi Filho, A Bozza et autres

PURPOSE: To evaluate the efficacy of diltiazem versus placebo in patients with stable angina. METHODS: Eight-seven angina pectoris patients, mean age of 57 +/- 9, 82 white and 79 male were evaluated in a randomized, double-blind trial of two groups of patients …

br (code pays fourni par la source)

Atrioventricular block in acute inferior wall myocardial infarction: Harbinger of associated obstruction of the left anterior descending coronary artery

Roberto Bassan, Ivan G. Maia, A Bozza, José Geraldo Amino et autres

[Initial experience. Comparative study of verapamil and nifedipine in the treatment of coronary insufficiency. Evaluation by a cycloergometric test].

R H Figueira, Freddy Enrique Ramos Guimarães, Michael Wagner, A Bozza et autres

[Multicentric study with perhexiline maleate in angina pectoris. Preliminary report].

Andréa da Nóbrega Cirino Nogueira, A Bozza, Britto Ah, D V Santos Filho et autres